|Company name||Amedisys, Inc.|
|Live stock price||[stckqut]AMED[/stckqut]|
|P/E compared to competitors||Good|
|Confident Investor Rating||Fair|
|Target stock price (TWCA growth scenario)||$28.48|
|Target stock price (averages with growth)||$23.88|
|Target stock price (averages with no growth)||$23.18|
|Target stock price (manual assumptions)||$23.86|
The following company description is from Google Finance: http://www.google.com/finance?q=amed
Amedisys, Inc. (Amedisys) is a healthcare company. Amedisys provides home health services to the chronic, co-morbid, aging American population. The Company operates in two segments: home health and hospice. Its home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. Its hospice segment provides palliative care and comfort to terminally ill patients and their families. As of December 31, 2010, Amedisys owned and operated 486 Medicare-certified home health agencies and 67 Medicare-certified hospice agencies in 45 states within the United States, the District of Columbia and Puerto Rico. During the year ended December 31, 2010, its home health and hospice services accounted approximately 86% of its revenue and was derived from Medicare. On June 7, 2011, the Company acquired Beacon Hospice, Inc.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. The stock has not been performing well lately and there may be better opportunities for your investment dollar.